Evaluating methylphenidate as a potential treatment for cocaine use disorder: a propensity score-matched study

Background: Cocaine’s psychoactive effects arise primarily from dopamine transporter (DAT) inhibition. Prior trials suggest methylphenidate, a DAT inhibitor with pharmacologic overlap with cocaine, may reduce cocaine use, but real-world data are limited.Objectives: To evaluate whether methylphenidate exposure is associated with reduced likelihood of subsequent positive cocaine screens among veterans treated within the VA healthcare system.Methods: This retrospective cohort study used the…

via https://pubmed.ncbi.nlm.nih.gov/41701923/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1L37KAMf2b_g4WEK3LmdFuKZu9pO3cN7u4ZmO9PPCPeBLMIw1q&fc=None&ff=20260225010905&v=2.18.0.post22+67771e2